252 related articles for article (PubMed ID: 25711282)
1. Combined Molecular Docking, 3D-QSAR, and Pharmacophore Model: Design of Novel Tubulin Polymerization Inhibitors by Binding to Colchicine-binding Site.
Li DD; Qin YJ; Zhang X; Yin Y; Zhu HL; Zhao LG
Chem Biol Drug Des; 2015 Oct; 86(4):731-45. PubMed ID: 25711282
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation and 3D-QSAR studies of novel 5-phenyl-1H-pyrazol cinnamamide derivatives as novel antitubulin agents.
Wang SF; Yin Y; Zhang YL; Mi SW; Zhao MY; Lv PC; Wang BZ; Zhu HL
Eur J Med Chem; 2015 Mar; 93():291-9. PubMed ID: 25703297
[TBL] [Abstract][Full Text] [Related]
3. Identification of Essential 2D and 3D Chemical Features for Discovery of the Novel Tubulin Polymerization Inhibitors.
Azimi F; Ghasemi JB; Saghaei L; Hassanzadeh F; Mahdavi M; Sadeghi-Aliabadi H; Scotti MT; Scotti L
Curr Top Med Chem; 2019; 19(13):1092-1120. PubMed ID: 31109275
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, molecular docking and biological evaluation of 1-phenylsulphonyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as novel potential tubulin assembling inhibitors.
Wang YT; Cai XC; Shi TQ; Zhang YL; Wang ZC; Liu CH; Zhu HL
Chem Biol Drug Des; 2017 Jul; 90(1):112-118. PubMed ID: 28032450
[TBL] [Abstract][Full Text] [Related]
5. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
Ahmadi S; Habibpour E
Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of (E)-3-(3,4-dihydroxyphenyl)acrylylpiperazine derivatives as a new class of tubulin polymerization inhibitors.
Yin Y; Qiao F; Jiang LY; Wang SF; Sha S; Wu X; Lv PC; Zhu HL
Bioorg Med Chem; 2014 Aug; 22(15):4285-92. PubMed ID: 24916028
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors.
Wang YT; Qin YJ; Yang N; Zhang YL; Liu CH; Zhu HL
Eur J Med Chem; 2015 Jun; 99():125-37. PubMed ID: 26070164
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site.
Lai Q; Wang Y; Wang R; Lai W; Tang L; Tao Y; Liu Y; Zhang R; Huang L; Xiang H; Zeng S; Gou L; Chen H; Yao Y; Yang J
Eur J Med Chem; 2018 Aug; 156():162-179. PubMed ID: 30006162
[TBL] [Abstract][Full Text] [Related]
9. The Design, Synthesis, and Biological Activities of Pyrrole-Based Carboxamides: The Novel Tubulin Inhibitors Targeting the Colchicine-Binding Site.
Boichuk S; Galembikova A; Syuzov K; Dunaev P; Bikinieva F; Aukhadieva A; Zykova S; Igidov N; Gankova K; Novikova M; Kopnin P
Molecules; 2021 Sep; 26(19):. PubMed ID: 34641324
[TBL] [Abstract][Full Text] [Related]
10. QSAR and 3D-QSAR models in the field of tubulin inhibitors as anticancer agents.
Marzaro G; Chilin A
Curr Top Med Chem; 2014; 14(20):2253-62. PubMed ID: 25434357
[TBL] [Abstract][Full Text] [Related]
11. Optimization of substituted cinnamic acyl sulfonamide derivatives as tubulin polymerization inhibitors with anticancer activity.
Luo Y; Zhou Y; Song Y; Chen G; Wang YX; Tian Y; Fan WW; Yang YS; Cheng T; Zhu HL
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3634-3638. PubMed ID: 30389289
[TBL] [Abstract][Full Text] [Related]
12. Discovery and molecular modeling of novel 1-indolyl acetate--5-nitroimidazole targeting tubulin polymerization as antiproliferative agents.
Duan YT; Sang YL; Makawana JA; Teraiya SB; Yao YF; Tang DJ; Tao XX; Zhu HL
Eur J Med Chem; 2014 Oct; 85():341-51. PubMed ID: 25105922
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of resveratrol-cinnamoyl derivates as tubulin polymerization inhibitors targeting the colchicine binding site.
Yin Y; Lian BP; Xia YZ; Shao YY; Kong LY
Bioorg Chem; 2019 Dec; 93():103319. PubMed ID: 31585270
[TBL] [Abstract][Full Text] [Related]
14. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations.
Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC
Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological evaluation and molecular modeling of 1,3,4-thiadiazol-2-amide derivatives as novel antitubulin agents.
Li YJ; Qin YJ; Makawana JA; Wang YT; Zhang YQ; Zhang YL; Yang MR; Jiang AQ; Zhu HL
Bioorg Med Chem; 2014 Aug; 22(15):4312-22. PubMed ID: 24909678
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of millepachine derivatives as a new class of tubulin polymerization inhibitors.
Wang G; Peng F; Cao D; Yang Z; Han X; Liu J; Wu W; He L; Ma L; Chen J; Sang Y; Xiang M; Peng A; Wei Y; Chen L
Bioorg Med Chem; 2013 Nov; 21(21):6844-54. PubMed ID: 23993668
[TBL] [Abstract][Full Text] [Related]
17. Structure-Based Pharmacophore Design and Virtual Screening for Novel Tubulin Inhibitors with Potential Anticancer Activity.
Zhou Y; Di B; Niu MM
Molecules; 2019 Sep; 24(17):. PubMed ID: 31480625
[TBL] [Abstract][Full Text] [Related]
18. Generation of ligand-based pharmacophore model and virtual screening for identification of novel tubulin inhibitors with potent anticancer activity.
Chiang YK; Kuo CC; Wu YS; Chen CT; Coumar MS; Wu JS; Hsieh HP; Chang CY; Jseng HY; Wu MH; Leou JS; Song JS; Chang JY; Lyu PC; Chao YS; Wu SY
J Med Chem; 2009 Jul; 52(14):4221-33. PubMed ID: 19507860
[TBL] [Abstract][Full Text] [Related]
19. Automated identification of structurally heterogeneous and patentable antiproliferative hits as potential tubulin inhibitors.
Mangiatordi GF; Trisciuzzi D; Iacobazzi R; Denora N; Pisani L; Catto M; Leonetti F; Alberga D; Nicolotti O
Chem Biol Drug Des; 2018 Jul; 92(1):1161-1170. PubMed ID: 29633572
[TBL] [Abstract][Full Text] [Related]
20. QSAR Modeling of the Arylthioindole Class of Colchicine Polymerization Inhibitors as Anticancer Agents.
Habibpour E; Ahmadi S
Curr Comput Aided Drug Des; 2017; 13(2):143-159. PubMed ID: 28120704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
